Phanes Therapeutics Announces Dose Expansion in Clinical Study of Spevatamig in Combination with Chemotherapy for Treatment of Biliary Tract Cancer
SAN DIEGO, April 08: Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development…
